• Explore /
  • Poster
  • / A phase I/IIa clinical trial investigating the therapeutic cancer vaccine UV1 in combination with ipilimumab in patients with malignant melanoma: Four-year survival update.

A phase I/IIa clinical trial investigating the therapeutic cancer vaccine UV1 in combination with ipilimumab in patients with malignant melanoma: Four-year survival update.

Abstract Poster

Authors

null

Espen Basmo Ellingsen

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

Espen Basmo Ellingsen, Elin Aamdal, Else Marit Inderberg, Wenche Rasch, Paal Brunsvig, Steinar Aamdal, Eivind Hovig, Marta Nyakas, Tormod Kyrre Guren, Gustav Gaudernack

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Vaccines and Oncolytic Viruses

Clinical Trial Registration Number

NCT02275416

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr 62)

Abstract #

62

Poster Bd #

C9

Abstract Disclosures

Similar Posters

First Author: Dung Thi Le

First Author: Guillermo De Velasco

First Author: Sofie Kirial Mørk

First Author: Koral Shah